Comparing Treatment of Dry Eye With Intracanlicular Dexamethasone, Restasis, and/or Lotemax
Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
This 6 month study seeks to compare the use of Intracanalicular Dexamethasone in conjunction
with Restasis (cyclosporine ophthalmic emulsion) for the treatment of signs and symptoms of
dry eye disease as compared to Restasis with Lotemax (loteprednol etabonate ophthalmic
suspension 0.5%) and Restasis monotherapy.